Publications by authors named "Gordon Rustin"

Claim this Profile
F
Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study.
Alice Bergamini, Ramya Ramaswami, Fieke Froeling, Panos Papanastasopoulos, Dee Short, Gordon John Sampson Rustin

Int J Gynecol Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A North-West London Experience of the Impact of Treatment Related Toxicity on Clinical Outcomes of Elderly Patients with Germ Cell Tumors.
Anand Sharma, Laura Morrison, Marina Milic, Aruni Ghose, Andrew Gogbashian, Gordon Rustin

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
Johnathan K Joffe, Fay H Cafferty, Laura Murphy, Gordon J S Rustin, Syed A Sohaib

J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.
Constantine Alifrangis, Anand Sharma, Shafi Chowdhury, Sarah Duncan, Marina Milic, Gordon Rustin

Eur J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial.
Robert D Morgan, Susana Banerjee, Marcia Hall, Andrew R Clamp, Cong Zhou, Gordon J S Rustin

Gynecol Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application.
Andrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, Laura Farrelly, Babasola Popoola, Gordon Rustin

Clin Trials· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer.
Ronald J Buckanovich, Gordon Rustin, Shitanshu Uppal, Alexander B Olawaiye, Joseph L Kelley

J Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome.
Marcia Hall, Konstantinos Savvatis, Katherine Nixon, Maria Kyrgiou, Kuhan Hariharan, Gordon Rustin

Ann Surg Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma.
Jonathan Shamash, Rizwan Syed, Shah-Jalal Sarker, Naveed Sarwar, Anand Sharma, Gordon J Rustin

Eur J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Martin Gore, Allan Hackshaw, William E Brady, Richard T Penson, Richard Zaino, Gordon Rustin

Gynecol Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Qualitative Analysis of the Impact of Carboplatin AUC 10 on Physical, Work Functioning and Bone Marrow Toxicity Among Seminoma Patients - A Single-centre Experience.
Marina Milic, Marcia Hall, Annette Hawkins, Andrew Gogbashian, Gordon Rustin

In Vivo· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers.
Ainhoa Madariaga, Gordon J S Rustin, Ronald J Buckanovich, Jonathan C Trent, Amit M Oza

Am Soc Clin Oncol Educ Book· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer.
Hayley S McKenzie, Graham Mead, Robert Huddart, Jeff D White, Gordon J S Rustin

Clin Genitourin Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Michael Friedlander, Ursula Matulonis, Charlie Gourley, Andreas du Bois, Ignace Vergote, Gordon Rustin

Br J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Not Give Up.
René Lynnette Roux, Marcia Rosalind Hall, Gordon John Sampson Rustin, Martin Zweifel

Int J Gynecol Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer.
Daniel Krell, Fran Said Battistino, Sarah Benafif, Lochani Ganegoda, Marcia Hall, Gordon J S Rustin

Int J Gynecol Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
Christian Marth, Ignace Vergote, Giovanni Scambia, Willi Oberaigner, Andrew Clamp, Gordon Rustin

Eur J Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin

Lancet Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin

Br J Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.
Christina Fotopoulou, Benjamin P Jones, Konstantinos Savvatis, Jeremy Campbell, Maria Kyrgiou, Gordon Rustin

Arch Gynecol Obstet· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Ursula A Matulonis, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin

Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
Jonathan A Ledermann, Andrew C Embleton, Fharat Raja, Timothy J Perren, Gordon C Jayson, Gordon J S Rustin

Lancet· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Support Groups Identifying Clinical Equipoise in UK Gynaecological Oncology Surgeons as the Basis for Trials in Ultraradical Surgery for Advanced Ovarian Cancer.
Raj Naik, Louise Bayne, Christina Founta, Sean Kehoe, Gordon Rustin

Int J Gynecol Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Amit M Oza, Adrian D Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A Ledermann, Gordon Rustin

Lancet Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors.
Chooi Peng Lee, N Jane Taylor, Gerhardt Attard, Simon Pacey, Paul D Nathan, Gordon J Rustin

Oncologist· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis